Journal of Diabetes Research / 2019 / Article / Tab 3

Research Article

Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity

Table 3

(a) Hormone levels in the study group at baseline: comparison with reference range

HormonesPatients on the aGLP-1, Reference range

Adiponectin (mcg/ml)
 Men8.9 (6.8; 17.1)>6
 Women10.1 (8.2; 13.8)9-12
Leptin (ng/ml)
 Men45.0 (8.0; 79.0)0.5-13.8
 Women32.5 (13.5; 52.5)1.1-27.6
Ghrelin fasting (pg/ml)1.6 (0.8; 2.7)8.502-16.6
Ghrelin after test (pg/ml)2.7 (1.4; 3.5)↓ 25-55% from baseline

2 hours after breakfast in the meal tolerance test. See reference [34].
(b) Hormone levels in the study group at baseline: comparison with control group

HormonesPatients on aGLP-1, Control group,

GLP-1 fasting (mmol/l)0.07 (0.01; 0.14)0.17 (0.12; 0.27)
GIP (pg/ml)391.6 (326.6; 461.4)574 (520.4; 744.5)

. .